What Is Microvascular Decompression? 3 Myths About the Misunderstood Treatment for Cranial Nerve Compression

If you suffer from a facial pain and spasm disorder, you know it doesn’t just hurt – it disrupts the simplest parts of your life. The unpredictability turns everyday activities like brushing your teeth, eating a meal, or having a conversation into opportunities for pain and anxiety.

Hemifacial spasm, trigeminal neuralgia, and glossopharyngeal neuralgia are rare conditions that may share a specific cause: a blood vessel pressing on a cranial nerve. Microvascular decompression (MVD) is a minimally invasive, nerve-sparing procedure that offers patients relief from pain and spasm.

MVD offers 80-90% of patients immediate symptom relief, with enduring relief over long-term follow-up. These outcomes are meaningful for patients whose symptoms are disruptive. Yet, MVD is still often delayed due to outdated conceptions about the procedure, who it is appropriate for, and when it should be used.

Dr. Stephen A. Johnson is a facial pain and spasm and trigeminal neuralgia specialist at Atlantic Brain and Spine (ABS). He is a highly skilled neurosurgeon with expertise in cranial nerve disorders and a leading expert in MVD.

“Microvascular decompression has come a long way from where it began. It is a safe, reliable surgery that can provide long-term relief,” he said. “It is the gold standard treatment for many patients with facial pain and spasm.”

What MVD Is – and What It Isn’t

MVD is a nerve-preserving operation that treats neurovascular compression. During the procedure, a neurosurgeon makes a quarter-sized incision behind the ear, identifies the blood vessel contacting the nerve, then gently repositions it and places a soft cushion between the vessel and nerve.

MVD is typically performed under general anesthesia. In select cases, an awake approach may be considered. Some patients experience rapid improvement after surgery. Most patients go home after a few days, with full recovery in a few weeks. Scarring is minimal, especially when the procedure is performed by an experienced, high-volume MVD surgeon like Dr. Johnson.

As Dr. Johnson explains, there are still misconceptions around MVD because of its experimental origins.

“When it was developed in the 1960s, MVD represented a big shift – treating the cause of nerve conditions by preserving the nerve instead of destroying it to stop symptoms,” he said. “It was also riskier, because it required operating near the brainstem back when imaging and microsurgical techniques weren’t what they are today.”

Modern MVD is a safe, well-established treatment for cranial nerve compression. Rather than a last resort, it can be a viable first option that stops the condition at its source so patients can go back to eating, talking, and smiling without fear or pain.

Why MVD Is Still Misunderstood: Three Myths That Delay Care

If MVD produces successful, long-lasting outcomes, why do so many patients arrive at it so late in their care? Despite progress, there are still a few persistent misconceptions that lead to delays.

Myth #1: “MVD is only for people with 10/10 pain.”

All too often, patients with cranial nerve disorders wait until they feel they’ve “earned” a surgical evaluation with debilitating pain or uncontrollable twitching. They may wind up in an escalating cycle of increasing symptoms, medication adjustments, and eroding quality of life before considering surgery.

Waiting can carry its own costs. Patients who delay evaluation and wait for their pain to escalate often experience:

• Medication toxicity or escalating side effects
• Episodes that become more frequent or harder to control
• Nerve changes that can complicate diagnosis
• Delayed referral to a specialist who regularly treats these disorders

“If an MRI or symptom pattern suggests neurovascular compression, a patient may be a candidate for MVD even if their pain is intermittent, atypical, or fluctuates below the ‘worst pain’ threshold,” said Dr. Johnson. “Evidence suggests that early treatment of these diseases is associated with better outcomes, so evaluation shouldn’t be delayed.”

Myth #2: “MVD is too risky.”

This perception is rooted in older eras of neurosurgery, when imaging and microsurgical techniques were less advanced and the risk was difficult to justify. Today’s MVD is built around precision and protection of critical cranial nerve function.

Modern developments in microsurgical techniques, combined with sophisticated imaging, advanced monitoring protocols, and shorter operative times, mean MVD is less invasive and safer than ever.

As with any brain surgery, MVD carries risk. However, they are often different from what patients imagine based on older descriptions of “skull surgery.” Complications such as hearing loss and cerebrospinal fluid leak are reported in a small percentage of cases, and recurrence can occur. Those risks should be discussed directly with a neurosurgeon.

Neurosurgeons at high-volume centers specializing in cranial nerve disorders – like the Facial Pain and Spasm Center at ABS – are highly experienced in performing the delicate MVD operation. The result: better outcomes and lower complication rates with faster recovery rates than many patients expect.

Myth #3: “Surgery should be a last resort.”

Non-surgical procedures like stereotactic radiosurgery or injections can be appropriate for certain patients depending on age, medical risk, and personal goals. They can reduce symptoms and may be appropriate for select situations.

The critical limitation is that these approaches typically do not treat the underlying cause when a vessel is compressing a cranial nerve. Pain may return, and repeat treatments can become less effective over time.

“Temporary or ablative options may ease a patient’s pain,” said Dr. Johnson. “But they don’t fix the underlying issue. MVD is the only treatment option that fixes the root cause of facial pain and spasm by releasing pressure on the affected nerve.”

Why Modern MVD Is Safer Than Ever

The current MVD procedure is the result of decades of innovation and refinement, with well-documented outcomes. Safety and success rates have been improved by significant advancements over the past half century, including:

• High-volume cranial nerve experience, which can improve outcomes and consistency
• Enhanced intraoperative monitoring to protect hearing, facial movement, and sensation
• Precision imaging to better identify neurovascular conflict
• Smaller incisions and less cerebellar retraction, which may reduce recovery time
• Shorter hospital stays, with many patients discharged in one to two days

Published findings consistently support MVD as a highly effective treatment for neurovascular compression disorders, including:

Glossopharyngeal Neuralgia: 85% of patients were pain-free immediately after surgery, with long-term relief in 65-90% of cases.

Hemifacial Spasm: 85-90% of hemifacial spasm patients experienced total pain relief, with relapses in just 1-2% of long-term follow-ups.

Trigeminal Neuralgia: 75.6% of patients with trigeminal neuralgia achieved pain freedom after MVD.

Outcomes at high-volume centers like the Facial Pain and Spasm Center at Atlantic Brain and Spine exceed the published averages, with over 90% of patients achieving pain freedom and an exceptionally low recurrence rates across all three conditions.

When to Consider MVD – and Where to Get the Best Treatment

MVD is considered the gold standard treatment for facial pain and spasm, and it can be a life-changing procedure for patients with facial pain and spasm. It may be worth considering if you’re experiencing any of the following:

• Electric-shock facial pain consistent with trigeminal neuralgia
• Disabling episodic attacks of pain or spasm that are affecting daily life
• Worsening hemifacial spasm or persistent facial twitching
• Medication failure or intolerable side effects
• Nerve compression indicated by imaging

Where you receive care matters. Because MVD is a precision operation performed around delicate cranial nerves, you benefit most from evaluation and treatment in a dedicated program with deep experience in facial pain and spasm disorders.

At Atlantic Brain and Spine, our Facial Pain and Spasm Center is the region’s only dedicated facility purpose-built to treat patients with trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia.

As a leading specialist in facial pain and spasm who trained under a leading expert in MVD, Dr. Johnson is dedicated to providing patients with a multimodal, tailored approach to their conditions. He is joined by fellowship-trained neurosurgeons with years of experience performing MVD for cranial nerve disorders:

• Ronald P. Benitez, facial pain and spasm and trigeminal neuralgia specialist and Medical Director of Endovascular Neurosurgery for Atlantic Health System
• Fabio A. Frisoli, neurosurgical skull base specialist and chairman of the Department of Neurosurgery at Overlook Medical Center
• Yaron A. Moshel, facial pain and spasm and trigeminal neuralgia specialist and Medical Director of Neurosurgery for Atlantic Health System

Together with multidisciplinary teams in neurology, pain management, and radiology, they provide patients with personalized care from diagnosis through long-term follow-up. With access to advanced imaging and the latest microsurgical technology, they ensure patients experience the best outcomes and smoothest recoveries.

You deserve to understand your options and regain control over your life. If you’re ready to face the world with confidence, request an appointment today.